Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wytske van Weerden"'
Autor:
Lisanne Mout, Ronald de Wit, Debra Stuurman, Esther Verhoef, Ron Mathijssen, Corrina de Ridder, Martijn Lolkema, Wytske van Weerden
Publikováno v:
EBioMedicine, Vol 27, Iss C, Pp 182-186 (2018)
Inactivation of the androgen receptor (AR) pathway by androgen deprivation therapy (ADT) is the mainstay of (metastatic) prostate cancer therapy. Ultimately, the AR pathway will be re-activated despite castrate levels of circulating androgens. Thereb
Externí odkaz:
https://doaj.org/article/a53255eaf8ca4bd1acb6440f9ba6db90
Autor:
Geert J L H van Leenders, Rajesh Sookhlall, Wilma J Teubel, Corrina M A de Ridder, Suzanne Reneman, Andrea Sacchetti, Kees J Vissers, Wytske van Weerden, Guido Jenster
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26753 (2011)
Prostate cancer consists of secretory cells and a population of immature cells. The function of immature cells and their mutual relation with secretory cells are still poorly understood. Immature cells either have a hierarchical relation to secretory
Externí odkaz:
https://doaj.org/article/431f6bd87c96437da1fa61c2a6d7647f
Autor:
Eline Ruigrok, Nicole Verkaik, Erik de Blois, Corrina de Ridder, Debra Stuurman, Stefan Roobol, Dik Van Gent, Marion de Jong, Wytske Van Weerden, Julie Nonnekens
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 8037
International Journal of Molecular Sciences, 23(14):8037. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, 23(14):8037. Multidisciplinary Digital Publishing Institute (MDPI)
Prostate specific membrane antigen targeted radionuclide therapy (PSMA-TRT) is a promising novel treatment for prostate cancer (PCa) patients. However, PSMA-TRT cannot be used for curative intent yet, thus additional research on how to improve the th
Autor:
Ellen, de Morrée, Robert, van Soest, Ashraf, Aghai, Corrina, de Ridder, Peter, de Bruijn, Inge, Ghobadi Moghaddam-Helmantel, Herman, Burger, Ron, Mathijssen, Erik, Wiemer, Ronald, de Wit, Wytske, van Weerden
Publikováno v:
The Prostate. 76(10)
Resistance to docetaxel is common in metastatic castration-resistant prostate cancer (mCRPC) and may be caused by sub-therapeutic intratumoral drug concentrations. Cabazitaxel demonstrated survival benefit in docetaxel-pretreated and docetaxel-refrac
Autor:
Ellen, Schenk, Magnus, Essand, Chris H, Bangma, Chris, Barber, Jean-Paul, Behr, Simon, Briggs, Robert, Carlisle, Wing-Shing, Cheng, Angelika, Danielsson, Iris J C, Dautzenberg, Helena, Dzojic, Patrick, Erbacher, Kerry, Fisher, April, Frazier, Lindsay J, Georgopoulos, Rob, Hoeben, Stefan, Kochanek, Daniela, Koppers-Lalic, Robert, Kraaij, Florian, Kreppel, Leif, Lindholm, Maria, Magnusson, Norman, Maitland, Patrick, Neuberg, Berith, Nilsson, Manfred, Ogris, Jean-Serge, Remy, Michelle, Scaife, Erik, Schooten, Len, Seymour, Thomas, Totterman, Taco G, Uil, Karel, Ulbrich, Joke L M, Veldhoven-Zweistra, Jeroen, de Vrij, Wytske, van Weerden, Ernst, Wagner, Ralph, Willemsen
Publikováno v:
Human gene therapy. 21(7)
Prostate cancer is at present the most common malignancy in men in the Western world. When localized to the prostate, this disease can be treated by curative therapy such as surgery and radiotherapy. However, a substantial number of patients experien
Autor:
Norman Maitland, Karen Chambers, Lindsay Georgopoulos, Martha Simpson-Holley, Regina Leadley, Helen Evans, Magnus Essand, Angelika Danielsson, Wytske van Weerden, Corrina de Ridder, Robert Kraaij, Chris H. Bangma
Publikováno v:
Human Gene Therapy; Jul2010, Vol. 21 Issue 7, p815-827, 13p
Autor:
Karin G. Hermans, Dirk C. van Alewijk, Joris A. Veltman, Wytske van Weerden, Ad Geurts van Kessel, Jan Trapman
Publikováno v:
Genes, Chromosomes & Cancer; Mar2004, Vol. 39 Issue 3, p171-184, 14p